- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01818154
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)
February 15, 2022 updated by: Iltefat Hamzavi, Henry Ford Health System
Validation of a New Hand Held Light Emitting Diode (LED) Device for the Determination of Minimal Erythema Dose (MED) for Narrowband Ultraviolet B.
The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Medical Center Department of Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 120 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
1. Age greater than 18 years.
Exclusion Criteria:
- Pregnancy
- Lactation
- History of photosensitivity disorder
- Photosensitizing medications
- Personal history of melanoma or non-melanoma skin cancer.
- Skin disease on the back
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Minimal Erythema Dose LED
A 2 x 2 cm section of skin will be exposed to LED light.
|
|
PLACEBO_COMPARATOR: Minimal Erythema Dose narrow band UVB
A 2 x 2 cm section of skin will be exposed to narrow band UVB light.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Minimal Erythema Dose
Time Frame: 1 day
|
The Investigator will look at area irradiated and evaluate for erythema.
The lowest dose at which erythema is noted will be recorded as the minimal erythema dose.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Iltefat H Hamzavi, M.D., Henry Ford Dermatology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (ACTUAL)
December 1, 2013
Study Completion (ACTUAL)
December 1, 2013
Study Registration Dates
First Submitted
March 20, 2013
First Submitted That Met QC Criteria
March 25, 2013
First Posted (ESTIMATE)
March 26, 2013
Study Record Updates
Last Update Posted (ACTUAL)
March 2, 2022
Last Update Submitted That Met QC Criteria
February 15, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7257
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phototherapy
-
University of Nove de JulhoUniversity of Bergen; Fundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Medical University of ViennaCompleted
-
Groupe Hospitalier Paris Saint JosephCompletedNeonatal PhototherapyFrance
-
Paulista UniversityCompletedTraining | Phototherapy | Autonomic Nervous SystemBrazil
-
Children's Hospital Medical Center, CincinnatiRecruiting
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompletedPhototherapy | Systemic | Low-level Laser TherapyBrazil
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompletedMuscle Development in Association to PhototherapyBrazil
-
Charite University, Berlin, GermanyTechnische Universität BerlinRecruiting
-
Wright State UniversityRecruitingAging | UVB Phototherapy Burn | Insulin-like Growth Factor 1United States
-
Universidade Estadual de LondrinaCompleted
Clinical Trials on LED phototherapy
-
GE HealthcareCompleted
-
Fatima Jinnah Medical UniversityCompleted
-
Aparecida Maria CataiFundação de Amparo à Pesquisa do Estado de São PauloUnknownType 2 Diabetes MellitusBrazil
-
Erebouni Medical CenterRecruitingNeonatal Hyperbilirubinemia | Jaundice, NeonatalArmenia
-
Institute of Biophysics and Cell Engineering of...Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyCompletedTreatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal FibroblastsNon-healing Wound | Trophic Ulcer | Non-Healing Ulcer of SkinBelarus
-
Professor Fernando Figueira Integral Medicine InstituteUnknownNeonatal HyperbilirubinemiaBrazil
-
Hermano Miguel FoundationCompletedSprains and Strains | Tendinopathy | Fasciitis | Epicondylitis | Muscle SpasmEcuador
-
Bryan TompsonCompletedThe Rate or Orthodontic Tooth MovementCanada
-
State University of New York - Downstate Medical...CompletedFibrosis | Scar | Keloid | Skin Wound | Hypertrophic Scar | Skin ScarringUnited States
-
Light Sciences LLCCompletedNeoplasm Metastasis | Liver Neoplasms | Colorectal Neoplasms | Liver MetastasisUnited States